Synthetic Biology Market Size & Share, by Technology (Genome Engineering, Bioinformatics); Application (Non-healthcare, Healthcare) - Global Supply & Demand Analysis, Growth Forecasts, Statistics Report 2023-2035

  • Report ID: 4810
  • Published Date: Apr 11, 2023
  • Report Format: PDF, PPT

Companies Dominating the Synthetic Biology Landscape

top-features-companies
    • Thermo Fisher Scientific Inc.
      • Company Overview
      • Business Strategy
      • Key Product Offerings
      • Financial Performance
      • Key Performance Indicators
      • Risk Analysis
      • Recent Development
      • Regional Presence
      • SWOT Analysis
    • Merck KGaA
    • Agilent Technologies Inc.
    • Danaher Corporation
    • GenScript Biotech Corporation
    • Twist Bioscience Corporation
    • Amyris, Inc.
    • Intrexon Corporation
    • Synthetic Genomics Inc.
    • Codexis, Inc.

Browse Key Market Insights with Data Illustration:

In-the-news

In The News

  • Thermo Fisher Scientific announced its acquisition of Mesa Biotech, a developer of point-of-care molecular diagnostic tests for infectious diseases, including COVID-19.

  • Merck KGaA announced a strategic collaboration with Artios Pharma, a company focused on DNA damage response therapies, to develop precision oncology treatment

 

s.


Author Credits:  Radhika Gupta, Shivam Bhutani


  • Report ID: 4810
  • Published Date: Apr 11, 2023
  • Report Format: PDF, PPT

Frequently Asked Questions (FAQ)

Favorable government initiatives, and growing focus on energy efficiency systems are the major factors driving the market growth.

The market size of synthetic biology is anticipated to attain a CAGR of 29.50% over the forecast period, i.e., 2023-2035.

The intellectual property rights, and regulatory challenges is estimated to be the growth hindering factors for the market expansion.

The market in the North America region is projected to hold the largest market share by the end of 2035 and provide more business opportunities in the future.

The major players in the market are Thermo Fisher Scientific Inc., Merck KGaA, GenScript Biotech Corporation, Twist Bioscience Corporation, Intrexon Corporation., and others.

The company profiles are selected based on the revenues generated from the product segment, the geographical presence of the company which determines the revenue generating capacity as well as the new products being launched into the market by the company.

The market is segmented by application, technology, and by region.

The healthcare segment is anticipated to garner the largest market size by the end of 2035 and display significant growth opportunities.
Inquiry Before Buying Request Free Sample
  GET A FREE SAMPLE

FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.

 Request Free Sample Copy

Have questions before ordering this report?

Inquiry Before Buying